pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme
Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
480 mg Piperaquine phosphate
Phase 1 · small molecule · Malaria
480 mg Piperaquine phosphate for Malaria is a Phase 1 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code QP17C19
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CNS Pharmaceuticals
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Malaria
- Status
- completed
- Trials
- 1